Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMMU $2.20 0.3800 +20.88%
SCLN $8.76 0.6500 +8.01%
VBLT $3.39 0.2300 +7.28%
PVCT $0.52 0.0298 +6.11%
SNSS $0.79 0.0250 +3.29%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

KITE $41.47 -5.7200 -12.12%
OHRP $3.16 -0.3700 -10.48%
PBYI $39.72 -4.2600 -9.69%
CRIS $1.42 -0.1500 -9.55%
ATRA $17.16 -1.6800 -8.92%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Next > | Last >>

Cancer Kills 7,500 Daily in China

(Yahoo! News/AFP) Jan 27, 2016 - Chronic infections, smoking and pollution have contributed to skyrocketing cases of cancer in China, with an estimated 4.3 million new diagnoses last year and 2.8 million deaths, researchers said Tuesday.
read article 



Recommendation to Omit Radiation Therapy after Lumpectomy for Some Breast Cancer Patients Is Frequently Not Implemented in Clinical Practice

(American College of Surgeons) Jan 27, 2016 - Nearly two thirds of U.S. women age 70 or older with stage I breast cancer who undergo lumpectomy and are eligible to safely omit subsequent radiation therapy (RT) according to national cancer guidelines still receive this treatment, according to new study results.
read press release 



Experts: High Drug Price Trend Has “Infected” Generics

(ASH) Jan 27, 2016 - An article published online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that pharmaceutical companies use several strategies to keep affordable generic drugs from the market, illustrating an emerging trend that authors say is becoming as harmful to consumers as high-cost brand-name drugs.
read press release 



NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

(MSK) Jan 27, 2016 - Together we, the National Cancer Institute (NCI)-designated Cancer Centers, recognize these low rates of HPV vaccination as a serious public health threat.
read article 



AVAX Technologies Announces Results Of Its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial In Patients With Relapsed Stage III Or IV Ovarian Cancer

(Yahoo! Finance) Jan 26, 2016 - AVAX Technologies, Inc., a pioneer in personalized cancer vaccines, today announced the results of its Phase 1/2 OVAX study in patients with platinum resistant relapsed Stage III or IV Ovarian Cancer.
read article 



BIND Therapeutics Provides Enrollment Update for Phase 2 iNSITE 1 and iNSITE 2 Trials with BIND-014

(Morningstar) Jan 27, 2016 - BIND Therapeutics, Inc. today announced that the iNSITE 1 trial in non-small cell lung cancer (NSCLC) with squamous histology is fully enrolled and data is expected to be available by the end of the first quarter of 2016.
read article 



Clovis Oncology Initiates Immunotherapy Combination Trial

(Clovis Oncology) Jan 27, 2016 - Study to evaluate the combination of rociletinib (CO-1686) with Genentech’s atezolizumab (MPDL3280A) for patients with advanced EGFR-mutant non-small cell lung cancer.
read corporate press release 



Important Falls In Death Rates From Leukemia In Europe Predicted For 2016

(ESMO) Jan 27, 2016 - Death rates from leukaemia among people of all ages in Europe are falling, according to the latest predictions for European cancer deaths in 2016, published in the leading cancer journal Annals of Oncology today.
read press release 



Study Shows Inferior Outcomes for African-American Pediatric Lymphoma Patients

(University of Miami/Miller School of Medicine) Jan 26, 2016 - Researchers from Sylvester Comprehensive Cancer Center have published a study showing that African-American pediatric Hodgkin lymphoma patients have inferior overall survival to their white and Hispanic peers.
read article 



Nivolumab Combined with Radiation Therapy May Be New Treatment Option for Patients with Melanoma Brain Metastases, Say Moffitt Cancer Center Researchers

(Moffitt) Jan 27, 2016 - The PD-1 targeting drug Nivolumab combined with stereotactic radiation resulted in minimal neurotoxicity in brain metastatic melanoma patients.
read press release 



Survival Period for Esophageal Cancer Is Tied to Race and Income

(Duke Medicine) Jan 26, 2016 - African-American patients with esophageal cancer survive fewer months after diagnosis than white patients, but only if they also have low incomes, according to a new study from Duke Health researchers.
read press release 



Smoking Lowers Breast Cancer Survival, Study Finds

(Philadelphia Inquirer/HealthDay News) Jan 26, 2016 - Women diagnosed with breast cancer who continue to smoke cigarettes are less likely to survive than those who never smoked or those who quit, new research finds.
read article 



Smokers Who Quit More Than 15 Years Ago Need Screening

(Mayo Clinic) Jan 26, 2016 - Expanding lung cancer screening to include people who quit smoking more than 15 years ago could detect more cases and further reduce associated mortality, according to a study by Mayo Clinic researchers published in the Journal of Thoracic Oncology.
read press release 



NHS Cancer Patients Gain Access To Four New Therapies

(PharmaTimes [UK]) Jan 27, 2016 - The National Institute for Health and Care Excellence has issued final recommendations endorsing National Health Service use of new therapies for ovarian cancer, multiple myeloma and prostate cancer, but rejecting one for gastric cancer.
read article 



BLA for Adalimumab Biosimilar Accepted for Review

(Monthly Prescribing Reference) Jan 26, 2016 - Amgen announced that the Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ABP 501, a biosimilar candidate to Humira (adalimumab).
read article (free registration required) 



Centene Searching For Hard Drives Containing Medical Data

(St. Louis Business Journal) Jan 26, 2016 - Centene Corp. is searching for six computer hard drives that contain the medical information for about 950,000 individuals.
read article 



Journal Editors To Researchers: Show Everyone Your Clinical Data

(NPR/Shots blog) Jan 26, 2016 - The world's leading medical journals have a proposal that could transform medical science: Researchers would have to publicly share their clinical data to get their studies published.
read article 



Two More Senators Now Holding Up FDA Nominee

(Washington Post/To Your Health) Jan 26, 2016 - Two additional senators have announced plans to stall the confirmation of a new Food and Drug Administration commissioner, with one citing the nominee's relationship to the pharmaceutical industry and the other saying the agency needs to reform the way it approves powerful opioid painkillers at the heart of a national epidemic of overdoses.
read article (free registration required) 



Women’s Heart Attacks Look Nothing Like Men’s: Report

(TIME) Jan 25, 2016 - A heart attack can look very different between genders.
read article 



Biosimilar Drugs Get Boost As UK Cost Agency Backs Their Use

(Reuters) Jan 26, 2016 - Cheaper "biosimilar" copies of expensive biotech drugs received a boost in Britain on Tuesday when the country's health cost-effectiveness agency NICE said patients needing such medicines "should be started with the least expensive drug”.
read article 



Cerner CEO Neal Patterson to Undergo Cancer Treatment, Calls Condition ‘Curable'

(Healthcare IT News) Jan 25, 2016 - CEO Neal Patterson said he was diagnosed with soft tissue cancer earlier in the month, adding that his physician said the disease had not progressed to any other area in his body. The electronic health record executive said he will still be involved in the business.
read article 



Upstate NY Factory Village's Trail Of Cancer Leads To Tap Water Probe

(The Citizen/Associated Press [Auburn, NY]) Jan 26, 2016 - After his factory worker father died a painful death from kidney cancer at age 68 in 2013, Michael Hickey made it his mission to find out why so many people in his hometown along the Hoosic River were getting sick.
read article 



293 At Risk Of HIV, Hepatitis Exposure Through Colonoscopies

(WWLP-22 News [Westfield, Mass.]) Jan 22, 2016 – Baystate Health says that some 293 patients who had colonoscopies at Baystate Noble Hospital years ago may have been exposed to blood-borne disease such as HIV, Hepatitis B, and Hepatitis C.
read article 



Medscape Malpractice Report 2015: Why Oncologists Get Sued

(Medscape Medical News) Jan 22, 2016 - Medscape surveyed nearly 4000 physicians, including oncologists, to find out whether and why they were sued for malpractice; how any lawsuit affected their careers and patient-care decisions; and what these doctors suggest to avoid or reduce the number of lawsuits.
read article (free registration required) 



Here Are The Sticking Points For Biden, Big Data And Cancer Moonshots

(Forbes) Jan 26, 2016 - Panelists at the World Economic Forum in Davos, Switzerland last week kept returning back to one common theme: To truly find a cure for cancer, we need better ways to collect, harness and analyze Big Data.
read article